Irreversibility of Symptoms with Biotin Therapy in an Adult with Profound Biotinidase Deficiency
Authors:
- 21 February 2017
- book chapter
- Published by Springer Nature
- Vol. 36, 117-120
Abstract
We report a 36-year-old woman who exhibited progressive optic atrophy at 13 years old, then stroke-like episodes and spastic diplegia in her 20s. Biotinidase deficiency was not readily considered in the differential diagnosis, and the definitive diagnosis was not made until pathological variants of the biotinidase gene (BTD) were found by exome sequencing. Profound biotinidase deficiency was confirmed by enzyme analysis. Unfortunately, her symptoms did not resolve or improve with biotin treatment. Biotin therapy is essential for all individuals with profound biotinidase deficiency and for preventing further damage in those who already exhibit irreversible neurological damage. Newborn screening for the disorder would have avoided years of clinical symptoms that now appear to be irreversible with biotin treatment.Keywords
This publication has 7 references indexed in Scilit:
- Biotinidase deficiency should be considered in individuals exhibiting myelopathy with or without and vision lossMolecular Genetics and Metabolism, 2015
- Biotinidase deficiency mimicking neuromyelitis optica: Initially exhibiting symptoms in adulthoodMultiple Sclerosis Journal, 2015
- Why screen newborns for profound and partial biotinidase deficiency?Molecular Genetics and Metabolism, 2015
- Biotinidase deficiency: “if you have to have an inherited metabolic disease, this is the one to have”Genetics in Medicine, 2012
- Delayed-onset profound biotinidase deficiencyThe Journal of Pediatrics, 1998
- Biotinidase deficiency: Initial clinical features and rapid diagnosisAnnals of Neurology, 1985
- Animal biotinidase.1965